MedPath

ROLE OF VITAMIN C AND THIAMINE IN SEPSIS INDUCED REFRACTORY HYPOTENSIO

Not Applicable
Conditions
Health Condition 1: R652- Severe sepsis
Registration Number
CTRI/2021/02/031043
Lead Sponsor
DR RAM MANOHAR LOHIA INSTITUTE OF MEDICAL SCIENCES
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1-PATIENTS WITH SEPTIC SHOCK WITH REFRACTORY HYPOTENSION

2-CONSENT FOR PARTICIPATION IN THE STUDY FROM LEGITIMATE GUARDIA

Exclusion Criteria

1-PREGNANCY

2-G6PD DEFICIENCY

3-PATIENTS ON ANTIPSYCHOTIC MEDICATIONS

4-PRE-EXISTING PULMONARY HYPERTENSION

5-H/O RENAL STONE,CHRONIC ALCOHOLISM,IRON OVERLOAD

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
TO EVALUATE THE EFFECTS OF VITAMIN-C AND THIAMINE ON MORTALITY BENEFIT IN PATIENTS WITH SEPSIS HAVING REFRACTORY HYPOTENSIONTimepoint: After 7 days from the time of start of vitamin-c or thiamine administration time
Secondary Outcome Measures
NameTimeMethod
TO STUDY THE EFFECTS OF VITAMIN-C AND THIAMINE ON HEMODYNAMIC PARAMETERS IN PATIENTS WITH SEPSIS HAVING REFRACTORY HYPOTENSIONTimepoint: 6 HOURLY MEASUREMENT OF HEMODDYNAMIC PARAMETERS FOR OVER 72 HOURS PERIOD FROM THE TIME OF ADMINISTRATION OF VITAMIN-C OR THIAMINE
© Copyright 2025. All Rights Reserved by MedPath